Toll-like receptor 2 activation by β2→1-fructans protects barrier function of T84 human intestinal epithelial cells in a chain length-dependent manner

J Nutr. 2014 Jul;144(7):1002-8. doi: 10.3945/jn.114.191643. Epub 2014 Apr 30.

Abstract

Dietary fiber intake is associated with lower incidence and mortality from disease, but the underlying mechanisms of these protective effects are unclear. We hypothesized that β2→1-fructan dietary fibers confer protection on intestinal epithelial cell barrier function via Toll-like receptor 2 (TLR2), and we studied whether β2→1-fructan chain-length differences affect this process. T84 human intestinal epithelial cell monolayers were incubated with 4 β2→1-fructan formulations of different chain-length compositions and were stimulated with the proinflammatory phorbol 12-myristate 13-acetate (PMA). Transepithelial electrical resistance (TEER) was analyzed by electric cell substrate impedance sensing (ECIS) as a measure for tight junction-mediated barrier function. To confirm TLR2 involvement in barrier modulation by β2→1-fructans, ECIS experiments were repeated using TLR2 blocking antibody. After preincubation of T84 cells with short-chain β2→1-fructans, the decrease in TEER as induced by PMA (62.3 ± 5.2%, P < 0.001) was strongly attenuated (15.2 ± 8.8%, P < 0.01). However, when PMA was applied first, no effect on recovery was observed during addition of the fructans. By blocking TLR2 on the T84 cells, the protective effect of short-chain β2→1-fructans was substantially inhibited. Stimulation of human embryonic kidney human TLR2 reporter cells with β2→1-fructans induced activation of nuclear factor kappa-light-chain-enhancer of activated B cells, confirming that β2→1-fructans are specific ligands for TLR2. To conclude, β2→1-fructans exert time-dependent and chain length-dependent protective effects on the T84 intestinal epithelial cell barrier mediated via TLR2. These results suggest that TLR2 located on intestinal epithelial cells could be a target of β2→1-fructan-mediated health effects.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / antagonists & inhibitors
  • Anti-Inflammatory Agents, Non-Steroidal / chemistry
  • Anti-Inflammatory Agents, Non-Steroidal / metabolism*
  • Antibodies, Blocking / pharmacology
  • Cell Line
  • Colon / drug effects
  • Colon / immunology
  • Colon / metabolism*
  • Diglycerides / pharmacology
  • Fructans / antagonists & inhibitors
  • Fructans / chemistry
  • Fructans / metabolism*
  • Gastrointestinal Agents / antagonists & inhibitors
  • Gastrointestinal Agents / chemistry
  • Gastrointestinal Agents / metabolism
  • Humans
  • Intestinal Mucosa / drug effects
  • Intestinal Mucosa / immunology
  • Intestinal Mucosa / metabolism*
  • Kidney / drug effects
  • Kidney / immunology
  • Kidney / metabolism
  • Ligands
  • Membrane Transport Modulators / antagonists & inhibitors
  • Membrane Transport Modulators / toxicity
  • Molecular Structure
  • NF-kappa B / agonists
  • NF-kappa B / metabolism
  • Oligopeptides / pharmacology
  • Prebiotics / analysis
  • Protective Agents / chemistry
  • Protective Agents / metabolism*
  • Recombinant Proteins / chemistry
  • Recombinant Proteins / metabolism
  • Tetradecanoylphorbol Acetate / analogs & derivatives
  • Tetradecanoylphorbol Acetate / antagonists & inhibitors
  • Tetradecanoylphorbol Acetate / toxicity
  • Tight Junctions / drug effects
  • Tight Junctions / immunology
  • Tight Junctions / metabolism*
  • Toll-Like Receptor 2 / agonists*
  • Toll-Like Receptor 2 / antagonists & inhibitors
  • Toll-Like Receptor 2 / genetics
  • Toll-Like Receptor 2 / metabolism
  • Transcription Factor AP-1 / agonists
  • Transcription Factor AP-1 / metabolism

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antibodies, Blocking
  • Diglycerides
  • FSL-1 lipoprotein, synthetic
  • Fructans
  • Gastrointestinal Agents
  • Ligands
  • Membrane Transport Modulators
  • NF-kappa B
  • Oligopeptides
  • Prebiotics
  • Protective Agents
  • Recombinant Proteins
  • TLR2 protein, human
  • Toll-Like Receptor 2
  • Transcription Factor AP-1
  • phorbolol myristate acetate
  • Tetradecanoylphorbol Acetate